Drugs / LORACARBEF ANHYDROUS
last change Nov 2018 re-read 2 minutes ago

LORACARBEF ANHYDROUS

Small molecule

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) LORABID 1996-11-13 fda.gov
Approved US (FDA) LORABID 1991-12-31 fda.gov

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as LORACARBEF ANHYDROUS ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as Anhydrous loracarbef ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as Lorabid ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as Loracarbef LoracarbefNCT02099240
Known as Loracarbef monohydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as Lorbef ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as LY-163892 ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Known as LY-163892 MONOHYDRATE ChEMBL registry synonym — accepted as the source's own label CHEMBL1013
Modality Small molecule CHEMBL1013